COM:GALECTINTHERAPEUTICS
Galectin Therapeutics
- Stock
Last Close
2.72
22/11 21:00
Market Cap
145.43M
Beta: -
Volume Today
132.79K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -12.09M - | -15.79M 30.61% | -20.03M 26.85% | -21.44M 7.04% | -16.23M 24.26% | -13.90M 14.38% | -13.29M 4.36% | -23.46M 76.51% | -30.53M 30.10% | -38.78M 27.02% | -41.07M 5.91% | |
depreciation and amortization | 12K - | 10K 16.67% | 7K 30% | 7K 0% | 1K 85.71% | 35K - | 36K 2.86% | 41K 13.89% | 32K 21.95% | 33K 3.13% | ||
deferred income tax | -3.79M - | -3.67M 3.14% | -3.40M 7.36% | -2.48M 27.09% | -138K - | -2.67M - | ||||||
stock based compensation | 3.79M - | 4.07M 7.42% | 3.40M 16.46% | 2.48M 27.09% | 1.10M 55.59% | 4.45M 303.72% | 1.68M 62.14% | 1.80M 6.89% | 2.08M 15.40% | 2.87M 38.10% | 2.26M 21.14% | |
change in working capital | 803K - | -1.12M 239.23% | -363K 67.53% | 2.54M 800% | -804K 131.64% | -1.07M 33.33% | 641K 159.79% | 942K 46.96% | 3.75M 298.20% | 4.97M 32.44% | 4.68M 5.84% | |
accounts receivables | ||||||||||||
inventory | ||||||||||||
accounts payables | -577K - | -783K 35.70% | -783K 0% | 2.42M 408.94% | -812K 133.57% | -1.09M 34.36% | 997K 191.38% | 2.54M 154.36% | 3.69M 45.35% | 4.24M 15.14% | 2.67M 37.06% | |
other working capital | 1.38M - | -335K 124.28% | 420K 225.37% | 122K 70.95% | 8K 93.44% | 19K 137.50% | -356K 1,973.68% | -1.59M 347.75% | 65K 104.08% | 724K 1,013.85% | 2.01M 177.21% | |
other non cash items | 3.79M - | 4.07M 7.42% | 3.40M 16.46% | 2.48M 27.09% | 45K 98.18% | 348K 673.33% | 87K 75% | 87K 0% | 489K 462.07% | -147K 130.06% | 3.80M 2,685.03% | |
net cash provided by operating activities | -7.48M - | -12.43M 66.03% | -16.98M 36.67% | -16.41M 3.38% | -15.89M 3.15% | -10.18M 35.95% | -10.85M 6.57% | -20.60M 89.91% | -24.31M 17.99% | -31.06M 27.76% | -32.97M 6.15% | |
investments in property plant and equipment | -5K - | |||||||||||
acquisitions net | -400K - | |||||||||||
purchases of investments | -400K - | |||||||||||
sales maturities of investments | ||||||||||||
other investing activites | 69K - | 400K 479.71% | -400K 200% | |||||||||
net cash used for investing activites | 64K - | -400K 725% | -400K 0% | |||||||||
debt repayment | -3.55M - | -30M - | -40.03M - | |||||||||
common stock issued | 3.83M - | 29.34M 665.38% | 13.70M 53.30% | 5.92M 56.75% | 3.58M 39.53% | 15.38M 329.22% | 50.47M 228.17% | 263K 99.48% | 6.81M 2,490.87% | 899K 86.81% | 40.03M 4,353.06% | |
common stock repurchased | 696K - | -30M - | 899K 103.00% | 671K 25.36% | ||||||||
dividends paid | -976K - | -943K 3.38% | -943K 0% | -741K 21.42% | -1.23M 66.26% | -915K 25.73% | -394K 56.94% | -137K 65.23% | -171K 24.82% | -97K 43.27% | -120K 23.71% | |
other financing activites | 5.75M - | 3.07M 46.61% | 943K 69.29% | 741K 21.42% | 4.09M 451.42% | 915K 77.61% | 50.47K 94.48% | 137K 171.45% | 90.17M 65,718.25% | 8.30M 90.80% | -551K 106.64% | |
net cash used provided by financing activities | 8.61M - | 31.46M 265.49% | 13.70M 56.46% | 5.92M 56.75% | 3.58M 39.53% | 15.38M 329.22% | 50.08M 225.61% | 263K 99.47% | 36.81M 13,897.72% | 10M 72.84% | 40.03M 300.33% | |
effect of forex changes on cash | -64K - | 400K - | ||||||||||
net change in cash | 1.13M - | 18.64M 1,556.80% | -3.28M 117.61% | -10.48M 219.44% | -12.31M 17.41% | 5.20M 142.25% | 39.23M 654.37% | -20.34M 151.85% | 12.51M 161.49% | -21.06M 268.37% | 7.07M 133.57% | |
cash at beginning of period | 9.36M - | 10.49M 12.01% | 29.13M 177.70% | 25.85M 11.27% | 15.36M 40.56% | 3.05M 80.13% | 8.25M 170.32% | 47.48M 475.31% | 27.14M 42.83% | 39.65M 46.08% | 18.59M 53.11% | |
cash at end of period | 10.49M - | 29.13M 177.70% | 25.85M 11.27% | 15.36M 40.56% | 3.05M 80.13% | 8.25M 170.32% | 47.48M 475.31% | 27.14M 42.83% | 39.65M 46.08% | 18.59M 53.11% | 25.66M 38.02% | |
operating cash flow | -7.48M - | -12.43M 66.03% | -16.98M 36.67% | -16.41M 3.38% | -15.89M 3.15% | -10.18M 35.95% | -10.85M 6.57% | -20.60M 89.91% | -24.31M 17.99% | -31.06M 27.76% | -32.97M 6.15% | |
capital expenditure | -5K - | |||||||||||
free cash flow | -7.49M - | -12.43M 65.92% | -16.98M 36.67% | -16.41M 3.38% | -15.89M 3.15% | -10.18M 35.95% | -10.85M 6.57% | -20.60M 89.91% | -24.31M 17.99% | -31.06M 27.76% | -32.97M 6.15% |
All numbers in USD (except ratios and percentages)